Active	Status	Sponsor type	Region	Phase	Filter
1 Active 2 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
SAIT101 (rituximab biosimilar) / Archigen Biotech
2011-004171-36: A study comparing SAIT101 to MabThera® in Subjects with Severe Rheumatoid Arthritis (RA)		3	50	Europe	SAIT101, MabThera®, SAIT101, MabThera®, MabThera®	Samsung Electronics Co. Ltd., Samsung Electronics Co. Ltd.	Severe Rheumatoid Arthritis (RA)		06/13